ALL Metrics
-
Views
-
Downloads
Get PDF
Get XML
Cite
Export
Track
Case Report

Case Report: Ayurvedic Vamana and Virechana treatment in hypothyroidism and conception in a woman seeking infertility treatment at an ART clinic

[version 1; peer review: 2 approved with reservations]
PUBLISHED 26 Jul 2023
Author details Author details
OPEN PEER REVIEW
REVIEWER STATUS

This article is included in the Datta Meghe Institute of Higher Education and Research collection.

Abstract

The most common condition impacting patients who present with ovulatory failure leading to infertility is hypothyroidism. Normal thyroxin levels and its milder counterpart, subclinical hypothyroidism, which is characterised by raised thyroid stimulating hormone (TSH) levels, may also be a factor in altered reproductive function. Conventional and persistent Panchkarma procedures, which include Vamana and Virechana Karma, foster wellness. Vamana and Virechana Karma symbolise the development of emesis and purification, resulting in improvements in the body’s capacity to eradicate toxins, especially through the intestine. Sroto shodhaka, Agnivardhaka, and dosha pratyanika chikitsa are the best therapies for hypothyroidism, assuming the prevalence of the Kapha and Pitta doshas. We found that Vamana and Virechana helped in the treatment of hypothyroidism. We report a case highlighting the beneficial effects of ayurvedic treatment of Vamana and Virechana in a woman with hypothyroidism seeking infertility treatment at our centre.

Keywords

Hypothyroidism, infertility, Vamana, ovulatory dysfunction, Thyroxine

Introduction

Infertility is defined as a failure to get pregnant after twelve months for women over the age of 30-40 or after one year of regular, unprotected sexual intercourse.1 Over the past several decades, the thyroid-stimulating hormone (TSH) was diagnosed to have a role in reproductive issues such as ovulatory dysfunction, infertility, miscarriage, and harmful maternal problems (gestational hypertension, preeclampsia, anaemia).2 Numerous studies have connected the physiology of reproduction, ovarian function, and thyroid function.3 The menstrual cycle, oestrogen and androgen metabolism, folliculogenesis, and endometrial receptivity may all be affected by TSH.4 The mainstream Indian medical practice referred to as Ayurveda continues to be among the oldest remaining common with an extensive intellectual and experimental foundation.5 The three fundamental ideas, known as doshas (vata, pitta, and kapha), are drawn from the five components of studies. Vata and its sub-doshas regulate input/output processes and motion. Pitta and its sub-doshas regulate throughtout, turnover, and thus energy, and Kapha and its sub-doshas regulate storage, structure, and lubrication. These fundamental physiological processes in living systems maintain their identity throughout their life history.6 Several instances of lifestyle disorders include diabetes insipidus, hypertension, and thyroid dysfunction. Thyroid disease is becoming more prevalent in society on a daily basis. In general population, hypothyroidism affects 3.8–6% of people.7 There are two types of thyroid dysfunction: overactivity (hyperthyroidism) and underactivity (hypothyroidism). The thyroid gland produces insufficient thyroid hormone in hyperthyroidism.8 An underactive thyroid is a common description of hypothyroidism. A common problem in women is hypothyroidism, who tend to demonstrate ovulatory disorders leading to infertility. Subclinical hypothyroidism (SH), a modestly raised level of TSH, is a milder form of hypothyroidism. The most frequent side effects of hypothyroidism include infertility, weight issues, depression, and chronic fatigue.8 The guru (heaviness) attribute of the kapha dosha is present in SH. It also possesses the manda, or dullness, attribute. Reducing manda guna of the Kapha dosha should be the primary goal of ayurvedic treatment for thyroid problems like hypothyroidism.

In this case report, a 29-year-old woman with hypothyroidism who had been married for the previous seven years is featured. The patient TSH level returned to within tentative normal range after receiving Vamana Virechhana treatment to diagnosed her doshas, which contributed to deal with patient’s infertility difficulties and thus, resulted in a positive clinical pregnancy.

Case presentation

Patient’s history

A 29-year-old South Asian woman who was a housewife by profession, with irregular menstrual cycles and infertility came to consult for her condition at our infertility centre. Thyroxine (T4) and triiodothyronine (T3) are the two main thyroid hormones that are inadequately produced by the thyroid gland in hypothyroidism. These hormones are crucial for controlling metabolism and maintaining the normal functioning of several organs and bodily systems.

Patient husband worked as a businessman. They were married for five years with no earlier conception. They were diagnosed with primary infertility. The family medical record reveals that there were no history of smoking, alcoholism or any other substance use. However, the female patient had undergone cholecystectomy two years prior to seeking treatment for infertility. Treatment, although the thyroxin medication was continued.

Family history

There was no family history of thyroid disease or any other affliction or disorder in the patient. Additionally, there was no history of infertility in the family.

Clinical findings

Female examination

According to laboratory tests, patient TSH level was 7.91 mU/L, which was over the average limit that was applicable to TSH. This could indicate hypothyroidism. The research of the patient’s husband’s semen analysis discovered a 79 million/mL count and 85% motility. It demonstrates that her male partner was not a factor in the couple’s infertility. Further research on haemoglobin showed 14 g/dL in females. Both a urine test and fasting plasma glucose results were within normal range. The results obtained from the pelvic uterine ultrasound were normal, and the ovaries seemed to be in good health. The other parts of the clinical examination seen to be in normal condition. The thyroid hormone, also known as profile (T3, T4, anti-thyroid peroxidase (Anti-TPO), and TSH was tested using an access immunoassay equipment. In addition, a urine test and fasting plasma glucose results were within normal range. The results of the pelvic uterine ultrasound were normal, and the ovaries appeared in optimal condition. The rest of the clinical examination average appeared to be in normal condition. The thyroid hormone profile (T3, T4, anti-thyroid peroxidase (Anti-TPO)) was tested using an access immunoassay instrument. T3 reported hormonal profile was 0.50 ng/mL, while T4 was four g/dL. T3 reported hormonal profile was 0.50 ng/mL, whereas T4 was 4 g/dL.

An important biomarker for determining a woman’s ovarian reserve is AMH (anti-Mullerian hormone).9 A normal ovarian reserve is often predicted by serum AMH levels between 2 to 6.8 ng/mL. The patient’s serum AMH value in our case study was 2.6 ng/mL. TSH levels of 15.91 mIU/L, FSH (follicle stimulating hormone) levels of 4.86 mIU/mL, oestrogen levels of 515.525 pg/mL, and LH (luteinizing hormone) levels of 8.85 IU/mL were identified in the patient’s hormonal level.

Performance quality of TSH hormones was determined using a quality control serum (Lyphocheck - Immunoassay Additionally from Bio-Rad, Hercules, CA). Anti-TPO antibody levels were greater than 30 nmol/L, and the T4 level was 0.8 ng/dL; T3 levels were below 100 ng/dL.

Diagnostic and treatment

Supplying of thyroid supplement however, didn’t result in considerable improvement in our patient. Hence, we opted for ayurvedic medications. We advised the patient to start with Go Ghrita 25 mL once a day on an empty stomach at around 7 am every day. The dosage was recommended to be gradually increased to 20 mL till the seventh day of the treatment. She was also advised medications for Vamana in the combination of Madan-Phal Pippali Churna 5 g along with Saindhava Lavana 1 g and honey 10 g once a day around 7 am on an empty stomach. For virechana medication, a combination of Kwath made from Draksha Churna 18 g, Aragwadha Churna 18 g, Haritiki Churna 20 g, Kutaki Churna 10 g in 500 mL of water, reducing it to 55 mL with Erand Tailam 40 mL, was advised to be taken in the evening. This treatment was advised to be followed for 30 days. After 30 days of treatment, we conducted a laboratory investigation of her thyroid profile again. Her TSH value was found to be 1.05 mIU/mL. This value indicated a normal thyroid parameter. We then planned to do further IVF treatment on the patient. ATSH was reduced to 3.73 mIU/L with the administration of 125 mcg of thyroid supplement tablets over a year in previous treatments.

She was started with a short antagonist protocol where in we started GnRH, clomiphene citrate and letrozole on the first day of her menstrual cycle. On day 13 of her menstrual cycle, we triggered the patient with HCG for the final preparation of ovum pickup (OPU). The maturation of follicles was observed via ultrasonography. Then, 36 hours after the trigger, we performed the OPU procedure on the patient. Four MII oocytes were retrieved during the procedure, and we then performed ICSI (intra-cytoplasmic sperm injection) on the oocytes. We conducted a fresh embryo transfer for the patient.

Follow up and outcomes

The patient was discharged after the embryo transfer went smoothly, with the recommendation to follow up. She was also instructed on the administration of intralipid injection, 500 mg of hydroxyprogesterone, and injectable human chorionic gonadotrophin (HCG). After two weeks had passed since the embryo transfer, we took a blood sample from the patient and sent it to our lab centre in Wardha for an HCG test. The final report was favourable, positive for pregnancy. The quantity of -HCG was 1150 mlU/mL, which indicates a positive clinical pregnancy outcome.

Discussion

Excessive hypothyroidism often results in infertility and delayed implantation. The direct effects that thyroid hormones have on oocytes indicate that they directly interfere with the normal function of the ovaries. They have an impact on how LH and FSH, which are used for the treatment of granulosa cell function, are controlled. Trophoblast differentiation function assists to maintain the foetal placenta’s integrity and protects against conceptus loss before birth.8

Hypothyroidism can be recognised according to the Ayurvedic perspective as a broad spectrum of afflication encompassing Kapha dusti (Kapha, one of Ayurveda’s three doshas, is associated with the elements of earth and water. The body’s lubrication, structure, and stability are all under its control, and an imbalance in Kapha can make one feel heavy and exhausted). Rasa Dhatu dusti (imbalance of plasma tissue), Udanavruta Samana (the Sanskrit word “Udanavruta Samana” can be found in the medication system known as Ayurveda. It represents a specific type of pranayama, or breath control method, used to balance and integrate the body’s energies. The breath is directed upward and outward in Udanavruta Samana, releasing the “udana” energy and nurturing balance), Kaphavruta Samana, Agnimandya (slowness of digestion, loss of appetite), Kaphaja galaganda (Dysentry phlegm mumps), among others. The clinical presentation resembles the Kapha-associated Pitta dusti with vitiation of Vata spurred on by Margavarana and predominantly Rasavaha and Medovaha srotodusti lakshans, which are frequently categorised as Bahudoshavastha.10 If hypothyroidism gets treated early, it can have a significant impact on the speed at which women with thyroid antibodies become pregnant (on average, three to four years later), as well as the probability the pregnancy will be miscarried.11 Considering its high prevalence in infertile women, hypothyroidism should be ruled out during general examination as often as possible. After a few attempts, we treated the patient with an Ayurvedic treatment named Kapha dosha. Guru, which means heaviness, is a characteristic of the Kapha dosha. Additionally, it had the manda, or dullness, attribute. Reducing manda guna of the Kapha dosha should be the main goal of ayurvedic treatment for thyroid disorders, including hypothyroidism. By getting TSH levels in the normal range, our patient’s SH was cured.6 It is important that TSH levels are in the normal range (0.5 to 5.0 mLU/L) for successful conception.

Conventionally and persistent Panchkarma procedures, which include Vamana and Virechana Karma, foster wellness.12 Vamana and Virechana Karma symbolise the development of emesis and purgation, resulting in improvements in the body’s capacity to eradicate toxins, especially through the intestine. This Karma tends to be classified into three categories: Mridu (mild), Madhya (middle), and Tikshna (strong), depending on the level of severity of the process. These Karma are additionally taken out in three steps: Poorva Karma, Pradhan Karma, and Pashchat Karma, much like other Karma. Before conducting this Karma, Sneha Pana, fomentation, and oil massage are recommended to liquefy Dosha and toxins. Sroto shodhaka, Agnivardhaka, and dosha pratyanika chikitsa are the best therapies for hypothyroidism, assuming the prevalence of the Kapha and Pitta doshas.13

This formed the preliminary basis of our application of Vamana and Virechana medication in our patient. It was observed that patient thyroid profile was significantly improved upon the administration of ayurvedic medication, which resulted in a positive clinical pregnancy outcome.

Conclusions

This case report examined the impact of ayurvedic Vamana and Virechana medication for the treatment of hypothyroidism, which resulted in infertility in our patient. Our result indicated that there was considerable significant improvement in the levels of TSH, which is a prerequisite factor for the determination of thyroid profile. Performing IVF treatment in our patient resulted in positive clinical pregnancy outcome.

Note

The study highlights the beneficial effects of Ayurveda an antiquated technique. We should carefully consider this particular concept.

Consent

The couple registered in our infertility clinic gave their written informed consent for the publication of this case report.

Comments on this article Comments (0)

Version 1
VERSION 1 PUBLISHED 26 Jul 2023
Comment
Author details Author details
Competing interests
Grant information
Copyright
Download
 
Export To
metrics
Views Downloads
F1000Research - -
PubMed Central
Data from PMC are received and updated monthly.
- -
Citations
CITE
how to cite this article
Dhote V, More A, Chaudhari N et al. Case Report: Ayurvedic Vamana and Virechana treatment in hypothyroidism and conception in a woman seeking infertility treatment at an ART clinic [version 1; peer review: 2 approved with reservations]. F1000Research 2023, 12:886 (https://doi.org/10.12688/f1000research.139044.1)
NOTE: If applicable, it is important to ensure the information in square brackets after the title is included in all citations of this article.
track
receive updates on this article
Track an article to receive email alerts on any updates to this article.

Open Peer Review

Current Reviewer Status: ?
Key to Reviewer Statuses VIEW
ApprovedThe paper is scientifically sound in its current form and only minor, if any, improvements are suggested
Approved with reservations A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit.
Not approvedFundamental flaws in the paper seriously undermine the findings and conclusions
Version 1
VERSION 1
PUBLISHED 26 Jul 2023
Views
3
Cite
Reviewer Report 06 Nov 2024
S Prashanth, Government Yoga and Naturopathy Medical College and Hospital, Chennai, India 
Approved with Reservations
VIEWS 3
Introduction:
The age of women facing infertility is mentioned as 30-40 years; your patient is 29 years old and has been having issues for the past 5 years, which means she has been infertile for the last 4 years, ... Continue reading
CITE
CITE
HOW TO CITE THIS REPORT
Prashanth S. Reviewer Report For: Case Report: Ayurvedic Vamana and Virechana treatment in hypothyroidism and conception in a woman seeking infertility treatment at an ART clinic [version 1; peer review: 2 approved with reservations]. F1000Research 2023, 12:886 (https://doi.org/10.5256/f1000research.152286.r336431)
NOTE: it is important to ensure the information in square brackets after the title is included in all citations of this article.
Views
6
Cite
Reviewer Report 11 Sep 2023
Soni Kapil, Department of Prasuti Tantra Evam Stree Roga,, RGGPG Ayurvedic College & Hospital, Paprola, Himachal Pradesh, India 
Approved with Reservations
VIEWS 6
I congratulate the authors for doing good work in the case of infertility associated with hypothyroidism, but a few essential details are missing from the research paper:
  • How did the authors determine that cycles of female
... Continue reading
CITE
CITE
HOW TO CITE THIS REPORT
Kapil S. Reviewer Report For: Case Report: Ayurvedic Vamana and Virechana treatment in hypothyroidism and conception in a woman seeking infertility treatment at an ART clinic [version 1; peer review: 2 approved with reservations]. F1000Research 2023, 12:886 (https://doi.org/10.5256/f1000research.152286.r200039)
NOTE: it is important to ensure the information in square brackets after the title is included in all citations of this article.

Comments on this article Comments (0)

Version 1
VERSION 1 PUBLISHED 26 Jul 2023
Comment
Alongside their report, reviewers assign a status to the article:
Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested
Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit.
Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions
Sign In
If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.

The email address should be the one you originally registered with F1000.

Email address not valid, please try again

You registered with F1000 via Google, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Google account password, please click here.

You registered with F1000 via Facebook, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Facebook account password, please click here.

Code not correct, please try again
Email us for further assistance.
Server error, please try again.